, Tracking Stock Market Picks
Enter Symbol:
Omeros Corporation (OMER) [hlAlert]

Mkt Outperform
up 73.75 %

Omeros Corporation (OMER) rated Mkt Outperform with price target $16 by Rodman & Renshaw

Posted on: Tuesday,  Mar 13, 2012  11:25 AM ET by Rodman & Renshaw

Rodman & Renshaw rated Mkt Outperform Omeros Corporation (NASDAQ: OMER) on 03/13/2012, when the stock price was $9.07.
Since then, Omeros Corporation has gained 73.76% as of 01/26/2016's recent price of $15.76.
If you would have followed this Rodman & Renshaw's recommendation on OMER, you would have gained 73.75% of your investment in 1414 days.

Omeros Corporation is a clinical-stage biopharmaceutical company engaged in discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. The Company?s clinically advanced product candidates are derived from its PharmacoSurgerytm platform designed to improve the clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Its PharmacoSurgery platform is based on low-dose combinations of therapeutic agents delivered directly to the surgical site throughout the duration of the procedure to preemptively inhibit inflammation and other problems caused by surgical trauma and to provide clinical benefits both during and after surgery.

Rodman & Renshaw is a full-service investment bank dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies. We also provide research and sales and trading services to institutional investor clients that focus on such companies. Since 2003, Rodman has been a leading investment banking firm to the biotechnology sector, a capital intensive market segment, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/13/2012 11:25 AM Buy
9.07 16.00
as of 12/31/2012
1 Week down  -14.63 %
1 Month down  -30.61 %
3 Months down  -44.78 %
1 YTD up  31.39 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/5/2011 8:25 AM Buy
3.99 13.00
4/1/2011 10:25 AM Hold
9/10/2010 9:25 AM Buy
6.43 20.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy